Not now, of course. Golden State is the class of the conference and Oklahoma City has one of the youngest starting lineups in the NBA. But the new Collective Bargaining Agreement offers hope to teams built to be balanced, not star heavy albeit a hope that likely wont be realized for two or three seasons. Read More Consider: Team executives believe that the rise of max salaries under the new CBA, coupled with the stabilizing of the salary cap, will lead to serious belt tightening across the NBA in the coming years. In Golden State, that will happen as early as this summer, when re-signing Kevin Durant who will likely opt out of the $27.7 million he is owed next season to sign a deal that would pay him in the mid-$30 million range could cost the Warriors key role players Andre Iguodala and Shaun Livingston, whose rights would need to be renounced to clear the necessary cap space to re-sign Durant. An even bigger decision could loom in 2019, when Klay Thompson is set to hit free agency. Will Golden State be willing to pay Thompson a max deal? And even if they wanted to, what kind of team could the Warriors field around their collection of stars? http://madeveoon.journalnewsnet.com/apart-from-the-fun-frolic-and-movement-college-also-provides-an-initial-fillip-that-you-need-for-a-superb-careerIts not just Golden State that will have headaches.
For the original version including any supplementary images or video, visit http://sports.yahoo.com/news/why-oklahoma-city-could-remain-the-best-fit-for-russell-westbrook-173034532.html
The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and The Bank of New York Mellon, as trustee (Trustee) and the conversion agent. referenceIn order to exercise the option to convert all or a portion of the Zero Coupon Notes, holders must validly surrender their Zero Coupon Notes at any time during the calendar quarter through the close of business at 5:00 p.m., New York City time, on Friday, March 31, 2017. The Trustee has informed LabCorp that, as of this date, all custodians and beneficial holders of the Zero Coupon Notes hold the Zero Coupon Notes through Depository Trust Company (DTC) accounts and that there are no certificated Zero Coupon Notes in non-global form. Accordingly, all Zero Coupon Notes surrendered for conversion must be delivered through the transmittal procedures of DTC. Should Zero Coupon Notes be converted, LabCorp would be required to pay holders in cash for the accreted principal amount of the securities to be converted, with the remaining amount, if any, to be satisfied with shares of Common Stock. The shares required for settlement of the Zero Coupon Notes are included in LabCorps computation of fully diluted earnings per share. About LabCorp Laboratory Corporation of America Holdings( LH ), anS&P500 company, is the worlds leading healthcare diagnostics company, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and develops technology-enabled solutions to change the way care is provided. With net revenue in excess of$8.5 billionin 2015, LabCorps 50,000 employees serve clients in 60 countries. To learn more about LabCorp, visit www.labcorp.com , and to learn more about Covance Drug Development, visit www.covance.com . This press release contains forward-looking statements including with respect to estimated 2016 guidance and the impact of various factors on operating results.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/conversion-triggered-labcorp-zero-coupon-134500166.html